FAIrPaCT - Federated Artificial Intelligence Framework to Optimise the Treatment of Pancreatic Cancer
Aims of this collaborative project
The goal of this consortium, consisting of the University Medical Center Göttingen, the University Hospital Giessen and Marburg and the Technical University Munich, is to develop a software
system supported by federated artificial intelligence called FAIrPaCT that will enable the analysis of clinical patient data and molecular cancer cell data from patients with pancreatic cancer across
institutes. Pancreatic cancer is a highly aggressive malignancy with a rising incidence, predicted to become the second leading cause of cancer-related death by 2030 in the industrialised world. Due
to its extraordinarily aggressive, locally invasive tumour biology with a tendency to distant metastases, and the exceptionally high and heterogeneous resistance to conventional
chemotherapy, therapy is often difficult.
Our project combines three of the largest patient cohorts (KFO5002, KFO325, SFB1321) on pancreatic cancer in Germany, which are unique in size and heterogeneity. In combination with innovatively tailored federated artificial intelligence methods, we are able to train robust high-performance models to estimate the probability of success for specific treatment approaches. Moreover, the FAIrPaCT framework will enable the identification of important parameters that drive treatment response, so called markers. These can provide key details about the molecular mechanisms that influence therapy success and thus can support the development of improved drugs and enable personalised treatment strategies. To address the needs of stakeholders such as medical and computational researchers, and patient communities all software packages will be open-source, data will be FAIR, and results will be published. Finally, moving towards cross-cohort analysis enables us to benefit from heterogeneous local data, to build more robust and clinically relevant models, identify globally relevant markers and ultimately make a step further towards artificial intelligence-supported precision medicine.
Overview of Work Packages
WP1: Project Management
WP2: Workshops on Data Science in Medicine
WP3: PDAC Data Management Framework
WP4: FAIR PDAC Register and Omics Data
WP5: FAI models for predicting treatment responses
WP6: Interpretation and xAI for PDAC Models
WP7: Framework Deployment and Evaluation
Contribution of the Department of Medical Bioinformatics
Our department will coordinate the Workpage 6: Interpretation and xAI for PDAC Models
This comprises extraction of clinically relevant features from the trained in the FAI models (WP5), statistical evaluation and interpretationof those features.
We will apply and extend in-house developed methods to interpret machine learning models especially in the context of molecular networks. These approaches will
elucidate potential causes and molecular mechanisms that drive the predictive performance of classifiers in PDAC.
Project partners
Location University of Göttingen/ University Medical Center Göttingen
Department of Medicals Informatics (UMG)
Prof. Dr. Anne-Christin Hausschild (Coordinator, PI WP1, WP2)
Prof. Dr. Uli Sax (PI WP3, WP7)
Department of Medical Bioinformatics (UMG)
Prof. Tim Beißbarth (PI, WP6)
Dr. Gregory Chereda
Clinic for General, Visceral and Paediatric Surgery
Clinic for Gastroenterology, Gastrointestinal Oncology and Endocrinology
Prof. Dr. Elisabeth Hessmann (PI, WP3)
Prof. Dr. Günther Schneider
Location Technical University of Munich
Medical Clinic and Polyclinic
Prof. Dr. Maximilian Reichert (PI)
Location Philipps University Marburg
Department of Internal Medicine, Gastroenterology, Endocrinology, Metabolism and Infectiology
Prof. Dr. Matthias Lauth (PI)
That might also interest you